BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KREF
2151
KKR Real Estate Finance Trust
KREF
$464M
| $119M | ﹤0.01% |
5,494,395
+26,527
| +0.5% | +$555K |
|
2152
Kymera Therapeutics
KYMR
$8.58B
| $119M | ﹤0.01% |
2,448,517
+934,594
| +62% | +$40.6M |
|
2153
United Microelectronic
UMC
$51.8B
| $118M | ﹤0.01% |
12,528,712
+5,168,856
| +70% | +$48.4M |
|
2154
HUTCHMED
HCM
$2.01B
| $118M | ﹤0.01% |
3,014,425
-603,523
| -17% | -$17.4M |
|
|
CHUY
2155
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $118M | ﹤0.01% |
3,167,284
-51,537
| -2% | -$2.19M |
|
|
RUTH
2156
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $118M | ﹤0.01% |
5,105,969
-136,113
| -3% | -$3.32M |
|
2157
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.17B
| $117M | ﹤0.01% |
+3,397,715
| New | +$111M |
|
|
SGMO
2158
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $117M | ﹤0.01% |
9,783,968
-4,046
| -0% | -$45.8K |
|
2159
HealthStream
HSTM
$895M
| $117M | ﹤0.01% |
4,188,795
-176,807
| -4% | -$4.45M |
|
2160
Heron Therapeutics
HRTX
$101M
| $117M | ﹤0.01% |
7,521,849
+384,539
| +5% | +$6.12M |
|
2161
Organogenesis Holdings
ORGO
$309M
| $117M | ﹤0.01% |
7,021,173
+4,730,593
| +207% | +$88.2M |
|
2162
Wipro
WIT
$20.4B
| $116M | ﹤0.01% |
29,718,696
-2,170,076
| -7% | -$8.1M |
|
2163
Arcutis Biotherapeutics
ARQT
$3.27B
| $116M | ﹤0.01% |
4,248,620
+46,661
| +1% | +$1.31M |
|
|
CBB
2164
DELISTED
Cincinnati Bell Inc.
CBB
| $116M | ﹤0.01% |
7,503,960
+28,184
| +0.4% | +$434K |
|
|
DNB
2165
DELISTED
Dun & Bradstreet
DNB
| $116M | ﹤0.01% |
5,414,543
-11,042,838
| -67% | -$247M |
|
|
JKS
2166
JinkoSolar
JKS
$827M
| $115M | ﹤0.01% |
2,058,533
+1,276,394
| +163% | +$48.7M |
|
2167
Hyatt Hotels
H
$16.4B
| $115M | ﹤0.01% |
1,479,003
-56,327
| -4% | -$4.55M |
|
2168
ICICI Bank
IBN
$109B
| $114M | ﹤0.01% |
6,694,360
+81,565
| +1% | +$1.36M |
|
2169
Compañía de Minas Buenaventura
BVN
$8.13B
| $114M | ﹤0.01% |
12,648,480
+415,899
| +3% | +$4.36M |
|
|
DNMR
2170
DELISTED
Danimer Scientific, Inc.
DNMR
| $114M | ﹤0.01% |
113,977
+77,588
| +213% | +$77.3M |
|
2171
Virtu Financial
VIRT
$5.12B
| $114M | ﹤0.01% |
4,127,823
+120,093
| +3% | +$3.57M |
|
|
CANO
2172
DELISTED
Cano Health, Inc.
CANO
| $114M | ﹤0.01% |
94,137
+86,913
| +1,203% | +$117M |
|
|
ABTX
2173
DELISTED
Allegiance Bancshares
ABTX
| $114M | ﹤0.01% |
2,957,512
-43,461
| -1% | -$1.75M |
|
2174
OceanFirst Financial
OCFC
$1.73B
| $114M | ﹤0.01% |
5,453,126
-189,093
| -3% | -$4.23M |
|
|
SPPI
2175
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $113M | ﹤0.01% |
30,194,887
+2,021,459
| +7% | +$7.02M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.